Home › Funds › Siren, L.L.C. › TSHA

Siren, L.L.C. position in TSHA

Taysha Gene Therapies, Inc. · Health Care

Siren, L.L.C. reported holding 9,846,579 shares of TSHA (Taysha Gene Therapies, Inc.) in its Q3 2026 13F filing — a position valued at US$48.0M, representing 1.14% of its reported portfolio and ranking #26 among its reported holdings. Siren, L.L.C. has disclosed TSHA holdings in 9 of the last 9 reported quarters, going back to Q3 2024.

Latest position (Q3 2026)9.85M sh
Reported value held$47.95M
Portfolio Weight1.14%
First reportedQ3 2024
Last changeHold
Updated2026-11-12

Last updated: 2026-11-12 · Source: SEC EDGAR Form 13F-HR

How Siren, L.L.C.'s TSHA position evolved

Siren, L.L.C. first disclosed a stake in TSHA in Q3 2024 at 4,879,875 shares (US$9.8M). The position peaked in Q2 2026 at 9,846,579 shares, worth US$67.1M. Across 9 filings, Siren, L.L.C. increased the stake 3 time(s), trimmed it 3 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 9,846,579 shares valued at US$48.0M. Notable position changes include a 35% increase in Q4 2024 (shares fell 20% over the following quarter), a 69% increase in Q2 2025 (shares rose 42% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2024 4.88M $9.81M New
Q4 2024 6.60M $11.42M Add
Q1 2025 6.51M $9.06M Reduce
Q2 2025 11.01M $25.44M Add
Q3 2025 11.01M $36.02M Hold
Q4 2025 10.13M $55.71M Reduce
Q1 2026 8.83M $39.47M Reduce
Q2 2026 9.85M $67.06M Add
Q3 2026 9.85M $47.95M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About TSHA and 13F data

TSHA (Taysha Gene Therapies, Inc.) is a Health Care company. 55 other funds we track also report a position in TSHA — the largest reported positions include Avoro Capital Advisors LLC (US$162.7M), RA CAPITAL MANAGEMENT, L.P. (US$160.4M), Vestal Point Capital, LP (US$132.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding TSHA

All TSHA fund holders →

FAQ

How long has Siren, L.L.C. held TSHA?

Siren, L.L.C. has disclosed TSHA holdings in 9 of the last 9 reported quarters, going back to Q3 2024.

What is Siren, L.L.C.'s current position in TSHA?

As of Q3 2026, Siren, L.L.C. holds 9.85M shares of TSHA (Taysha Gene Therapies, Inc.), valued at $47.95M, representing 1.14% of its reported portfolio and ranking #26.

Has Siren, L.L.C. been buying or selling TSHA?

In the latest 13F filing (Q3 2026), Siren, L.L.C. held unchanged its position in TSHA. The position peaked in Q2 2026 at 9.85M shares.

Which other funds hold TSHA?

Other major institutional holders of TSHA include Avoro Capital Advisors LLC, RA CAPITAL MANAGEMENT, L.P., Vestal Point Capital, LP, among 55 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.